[
    {
        "question": "The risk of carbamazepine induced Stevens-Johnson syndrome is increased in the presence of which of the following genes?",
        "exp": "HLA DRUG DISEASE B1502 CARBAMAZEPINE STEVEN JOHNSON SYNDROME B5801 ALLOPURINOL SKIN REACTION B5701 ABACAVIR MI B53 MALARIA PROTECTION B27 ANKYLOSING SPONDYLITIS",
        "cop": 2,
        "opa": "HLA-B* 5801",
        "opb": "HLA-B* 1502",
        "opc": "HLA-B* 5701",
        "opd": "HLA-B 27",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "9cf11a9a-eb54-458b-8fa0-5fada2947b0a",
        "choice_type": "single"
    },
    {
        "question": "Midostaurin is a new drug used for the treatment of:",
        "exp": "Midostaurin: Multitargeted protein kinase inhibitor indicated along with standard cytarabine and daunorubicin for adult with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation positive.",
        "cop": 3,
        "opa": "CML",
        "opb": "ALL",
        "opc": "AML",
        "opd": "CLL",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "6b799433-0065-4cdc-a2c7-e5f0e0614d44",
        "choice_type": "multi"
    },
    {
        "question": "Table sugar can be used for treatment of hypoglycaemia secondary to all of the following drugs EXCEPT:",
        "exp": "Acarbose: Alpha glucosidase inhibitor, stops the conversion of sucrose to glucose. Therefore using table sugar for treatment of hypoglycemia when patient is on acarbose is not useful. MOA: Located in the intestinal brush border, a-glucosidase enzymes break down carbohydrates into glucose and other simple sugars that can be absorbed. Acarbose and miglitol reversibly inhibit a-glucosidase enzymes. Major s/e are flatulence, diarrhea and abdominal cramping.",
        "cop": 1,
        "opa": "Acarbose",
        "opb": "Metformin",
        "opc": "Glipizide",
        "opd": "Insulin",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "3ef86127-3036-49fd-b3fc-bef2471f90ee",
        "choice_type": "multi"
    },
    {
        "question": "All the following drugs are used in the treatment of metastatic breast cancer except:",
        "exp": "Sunitinib is a novel oral multitargeted tyrosine kinase inhibitor with antitumor and antiangiogenic activities. It was recently approved in first-line treatment for patients with advanced renal cell carcinoma (RCC) and for the treatment of patients with gastrointestinal stromal tumors (GIST). Ixabepilone: Antimicrotubule inhibitor(M Phase): use for breast cancer Abemaciclib and Ribocilib: CDK-4 and CDK-6 inhibitor use in breast cancer",
        "cop": 4,
        "opa": "Ixabepilone",
        "opb": "Abemaciclib",
        "opc": "Ribociclib",
        "opd": "Sunitinib",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "6aa77f9e-6f9b-4d63-ac3e-75f99b54a8e6",
        "choice_type": "multi"
    },
    {
        "question": "Which of the following antimicrobial shows time dependent killing?",
        "exp": "Bactericidal agents can be divided into two groups: Agents that exhibit concentration-dependent killing (e. g. aminoglycosides and quinolones) Agents that exhibit time-dependent killing (e. g., b lactams and vancomycin).",
        "cop": 3,
        "opa": "Ofloxacin",
        "opb": "Amikacin",
        "opc": "Penicillin",
        "opd": "Ciprofloxacin",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "2cb233db-4e42-4d59-99c9-5f09d03e97e4",
        "choice_type": "single"
    },
    {
        "question": "Which is not an osmotic laxative?",
        "exp": "Laxatives Bulk forming Dietary fibre Osmotic Sorbitol Lactulose Polyethylene glycol Mg(OH)2 Mg. SO4 Stimulant Senna Cascara Bisacodyl",
        "cop": 4,
        "opa": "Sorbitol",
        "opb": "Magnesium Hydroxide",
        "opc": "Polyethylene glycol",
        "opd": "Bisacodyl",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "de96f736-23a4-4f8b-894c-1fbe5bc27e11",
        "choice_type": "single"
    },
    {
        "question": "Newer monoclonal antibody approved for rheumatoid ahritis is:",
        "exp": "Sarilumab: Monoclonal antibody against IL6, used for rheumatoid ahritis. Six - SARILUMAB - monoclonal antibody | Interleukin Durvalumab: Monoclonal antibody for urothelial carcinoma. DURVALUMAB - Urothelial Ca Nivolumab/Sarilumab: Monoclonal antibody for non small cell lung cancer(NSCLC). Durvalumab, Nivolumab, Sarilumab: Target program death ligand of T cell. T cell get activated and kills cancer cells.",
        "cop": 4,
        "opa": "Durvalumab",
        "opb": "Pembrolizumab",
        "opc": "Nivolumab",
        "opd": "Sarilumab",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "c89d37f3-2f30-489e-96f5-e54968c466a0",
        "choice_type": "single"
    },
    {
        "question": "Tetrabenazine acts by inhibiting",
        "exp": "Tetrabenazine: Inhibit VMAT 2(vesicular monoamine transpoer), which transpo dopamine and norepinephrine into adrenergic vesicle in nerve ending. Use for treatment of chorea in Huntington and tardive dyskinesia. In above figure: Pharmacologic strategies for dopaminergic therapy of Parkinson's disease. Drugs and their effects are indicated (see text). MAO, monoamine oxidase; COMT, catechol-O-methyltransferase; DOPAC, dihydroxyphenylacetic acid; L-DOPA, levodopa; 3-OMD, 3-O-methydopa; 3-MT, 3-methoxytramine.",
        "cop": 2,
        "opa": "MAO-B",
        "opb": "Vesicular monoamine transpoer",
        "opc": "Dopamine D2 receptors",
        "opd": "COMT",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "404be195-b477-46fa-83b4-63d059d7f9bc",
        "choice_type": "single"
    },
    {
        "question": "Warfarin induced skin necrosis is seen in:",
        "exp": "It is due to decreased levels of protein C. It is more likely to occur in patients with genetic deficiency of protein C. Most common side effect of warfarin: Bleeding Dermal vascular necrosis is early appearing adverse effect. Due to decreased osteocalcin synthesis Warfarin causes nasal hypoplasia and therefore contraindicated in pregnancy",
        "cop": 1,
        "opa": "Protein C deficiency",
        "opb": "Sickle cell anemia",
        "opc": "Factor V leiden deficiency",
        "opd": "Antithrombin 3 deficiency",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "28888163-4ad9-4bcf-907b-b73d39c3ee98",
        "choice_type": "single"
    },
    {
        "question": "DPP-IV inhibitor that can be used in renal failure is:",
        "exp": "Alogliptin, linagliptin, saxagliptin and sitagliptin are orally active dipeptidyl peptidase-4 (DPP-4) inhibitors used for the treatment of type 2 diabetes. Mechanism of action: These drugs inhibit the enzyme DPP-4, which is responsible for the inactivation of incretin hormones such as GLP-1. Prolonging the activity of Incretin hormones increases insulin release in response to meals and reduces inappropriate secretion of glucagon. These drugs are avoided in renal failure except linagliptin which can be use in renal failure.",
        "cop": 1,
        "opa": "Linagliptin",
        "opb": "Sitagliptin",
        "opc": "Vildagliptin",
        "opd": "Sexagliptin",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "0742c506-15b3-41a2-83d6-a6bc74e9c0e5",
        "choice_type": "single"
    },
    {
        "question": "Lubiprostone is a:",
        "exp": "Lubiprostone:- selectively stimulates type 2 chloride channels in epithelial cells thereby causing an efflux of chloride into the intestinal lumen. - The resultant fluid secretion into the gastrointestinal lumen provides a bolus effect that softens stool, increases intestinal transit, and improves symptoms of constipation. - Lubiprostone acts locally within the intestinal tract, is rapidly metabolized, and has very low systemic bioavailability.",
        "cop": 1,
        "opa": "Chloride channel activator",
        "opb": "Chloride channel inhibitor",
        "opc": "Sodium channel activator",
        "opd": "Sodium channel inhibitor",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "a5e7c0c6-8c04-40dd-9869-867942df5a4d",
        "choice_type": "single"
    },
    {
        "question": "Which of the following statement is false regarding Leflunomide:",
        "exp": "Leflunomide is a prodrug of an inhibitor of pyrimidine synthesis by inhibiting enzyme dihydro orotate dehydrogenase thereby inhibiting proliferation of T and B cell. Toxicities include elevation of liver enzymes with some risk of liver damage, renal impairment, and teratogenic effects. It is approved only for rheumatoid ahritis at present, although studies are underway combining leflunomide with mycophenolate mofetil for a variety of autoimmune and inflammatory skin disorders, as well as preservation of allografts in solid organ transplantation. Mycophenolate mofetil: Act by inhibiting IMP dehydrogenase enzyme, suppresses both B and T-lymphocyte.",
        "cop": 2,
        "opa": "Used in treatment of Rheumatoid ahriti",
        "opb": "Act by inhibiting IMP dehydrogenase enzyme",
        "opc": "Inhibits proliferation of T and B cells",
        "opd": "It is contraindicated in pregnancy",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "c635f1d3-6b59-4d3b-84e9-857bf34f54e6",
        "choice_type": "multi"
    },
    {
        "question": "New drug approved for treatment of tardive dyskinesia is:",
        "exp": "Tardive dyskinesia is late symptom which appears on treatment with typical antipsychotic like haloperidol. It occurs due to D2 receptor supersensitivity. Treatment of choice isvalbenazine Tetrabenazine and deutetrabenazine are use in Huntington's chorea. Safinamide is a new MAO B inhibitor which is use for treatment of Parkinson.",
        "cop": 3,
        "opa": "Safinamide",
        "opb": "Tetrabenazine",
        "opc": "Valbenazine",
        "opd": "Deutetrabenazine",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "4a7c9cd9-fdd9-4ca4-9eb8-aeae8396d70f",
        "choice_type": "single"
    },
    {
        "question": "All can cause serotonin increase except:",
        "exp": "Stimulant drugs commonly abused in the USA include methamphetamine (crank, crystal) methylenedioxymethamphetamine (MDMA, ecstasy) act's to increase 5. HT. SSRI like fluoxetine and paroxetine increase serotonin level and can lead to excessive serotonin response when administered with other serotonergic drug like MAOIs. LSD act on 5. HT serotonin receptor but does not increase serotonin level.",
        "cop": 4,
        "opa": "MDMA",
        "opb": "Amphetamine",
        "opc": "Fluoxetine",
        "opd": "LSD",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "e4cc94ca-339e-486f-bac1-de3bcba88ad9",
        "choice_type": "multi"
    },
    {
        "question": "Which of the following is a guanylate cyclase agonist used in irritable bowel syndrome?",
        "exp": "Linaclotide is a poorly absorbed 14-amino-acid peptide that binds to the guanylate cylase C receptor on the luminal surface of intestinal enterocytes, activating the cystic fibrosis transmembrane chloride conductance channel and stimulating intestinal fluid secretion. Therefore it is use in irritable bowel syndrome. Lubiprostone selectively stimulates type 2 chloride channels in epithelial cells thereby causing an efflux of chloride into the intestinal lumen. The resultant fluid secretion into the gastrointestinal lumen provides a bolus effect that softens stool, increases intestinal transit, and improves symptoms of constipation. Lubiprostone acts locally within the intestinal tract, is rapidly metabolized, and has very low systemic bioavailability. Tegaserod is a serotonin 5-HT 4 paial agonist that has high affinity for 5-HT 4 receptors but no appreciable binding to 5-HT 3 or dopamine receptors. Tegaserod was approved for the treatment of patients with chronic constipation and IBS with predominant constipation. Methylnaltrexone: opioid receptor antagonist/approved for the treatment of opioid-induced constipation in patients receiving palliative care for advanced illness who have had inadequate response to other agents. It is administered as a subcutaneous injection (0. 15 mg/kg) every 2 days.",
        "cop": 2,
        "opa": "Lubiprostine",
        "opb": "Linaclotide",
        "opc": "Tegaserod",
        "opd": "Methyl naltrexone",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "584b5b3e-ee09-49d0-ad42-08b6f493bb81",
        "choice_type": "single"
    },
    {
        "question": "Lenalidomide co-administration with which another drug increases the risk of thrombosis?",
        "exp": "Recently, combination regimens incorporating lenalidomide plus dexamethasone or prednisone have been shown to be more effective as first-line therapy. Lenalidomide was approved by the Food and Drug Administration (FDA) in late 2005 as a consequence of trials that showed its effectiveness in the treatment of the myelodysplastic syndrome with the chromosome 5q31 deletion. Clinical trials using lenalidomide to treat newly diagnosed as well as relapsed or refractory multiple myeloma showed similar efficacy, leading to FDA approval for myeloma as well. Its side effect profile is similar to that of thalidomide, although with less teratogenic effect and fewer thromboembolic events.",
        "cop": 3,
        "opa": "Alcohol",
        "opb": "Barbiturates",
        "opc": "Glucocoicoids",
        "opd": "Antibiotics",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "f6dc3f92-a841-4a5b-b4cc-92aa92b39d95",
        "choice_type": "single"
    },
    {
        "question": "Denosumab is a monoclonal antibody used for the treatment of:",
        "exp": "Denosumab is a monoclonal antibody against RANK - ligand which inhibits binding to RANK receptor and inhibits the activation of osteoclasts and inhibits bone resorption so it is used in treatment of Osteoporosis.",
        "cop": 3,
        "opa": "Osteomalacia",
        "opb": "Osteoahritis",
        "opc": "Osteoporosis",
        "opd": "Breast carcinoma",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "7a5d7dbb-4989-4c0a-9de8-350e434ce134",
        "choice_type": "single"
    },
    {
        "question": "Cobicistat is used along which of the following antiretroviral drug?",
        "exp": "Cobicistat, with trade name Tybost (formerly GS-9350) is a licensed drug for use in the treatment of human immunodeficiency virus infection (HIV/AIDS). Its major mechanism of action is through the inhibition of human CYP3A proteins. Like ritonavir (Norvir), cobicistat is of interest for its ability to inhibit liver enzymes that metabolize other medications used to treat HIV, notably elvitegravir, an HIV integrase inhibitor and darunavir. By combining cobicistat with elvitegravir, higher concentrations of the latter are achieved in the body with lower dosing, theoretically enhancing elvitegravir's viral suppression while diminishing its adverse side-effects. Indinavir and Ritonavir both are use protease inhibitor use for HIV patient.",
        "cop": 2,
        "opa": "Indinavir",
        "opb": "Darunavir",
        "opc": "Ritonavir",
        "opd": "Saquvinavir",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "92d8b2d9-aae0-4c0e-bb8e-7c46e6092e6e",
        "choice_type": "single"
    },
    {
        "question": "Which drug has inverse agonist activity at benzodiazepine receptors?",
        "exp": "Benzodiazepine Binding Site Ligands: The components of the GABA A receptor-chloride ion channel macromolecule that function as benzodiazepine binding sites exhibit heterogeneity. Three types of ligand-benzodiazepine receptor interactions have been repoed: Agonists: facilitate GABA actions, and this occurs at multiple BZ binding sites in the case of the benzodiazepines. Antagonists are typified: by the synthetic benzodiazepine derivative flumazenil. Inverse agonists act as negative allosteric modulators of GABA-receptor function. Their interaction with BZ sites on the GABA A receptor can produce anxiety and seizures, an action that has been demonstrated for several compounds especially the b carbolines Naltrexone: Opioid receptor antagonist. Zopiclone: In contrast to benzodiazepines, zolpidem, zaleplon, and eszopiclone bind more selectively because these drugs interact only with GABA A -receptor isoforms that contain a1 subunits.",
        "cop": 2,
        "opa": "Flumazenil",
        "opb": "Beta carboline",
        "opc": "Naltrexone",
        "opd": "Zopiclone",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2017",
        "id": "c6a5b265-7cbc-47eb-b938-26c7c3dc3ff6",
        "choice_type": "single"
    }
]